Kane Biotech Inc.

TSXV:KNE Stock Report

Market Cap: CA$15.8m

Kane Biotech Management

Management criteria checks 2/4

Kane Biotech's CEO is Marc Edwards, appointed in Sep 2018, has a tenure of 6.17 years. total yearly compensation is CA$406.83K, comprised of 61.5% salary and 38.5% bonuses, including company stock and options. directly owns 4.64% of the company’s shares, worth CA$734.06K. The average tenure of the management team and the board of directors is 2.6 years and 6.2 years respectively.

Key information

Marc Edwards

Chief executive officer

CA$406.8k

Total compensation

CEO salary percentage61.5%
CEO tenure6.2yrs
CEO ownership4.6%
Management average tenure2.6yrs
Board average tenure6.2yrs

Recent management updates

Recent updates

Here's Why Kane Biotech (CVE:KNE) Can Afford Some Debt

Nov 05
Here's Why Kane Biotech (CVE:KNE) Can Afford Some Debt

Is Kane Biotech (CVE:KNE) A Risky Investment?

Jul 14
Is Kane Biotech (CVE:KNE) A Risky Investment?

Is Kane Biotech (CVE:KNE) A Risky Investment?

Mar 27
Is Kane Biotech (CVE:KNE) A Risky Investment?

CEO Compensation Analysis

How has Marc Edwards's remuneration changed compared to Kane Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CA$5m

Mar 31 2024n/an/a

-CA$5m

Dec 31 2023CA$407kCA$250k

-CA$5m

Sep 30 2023n/an/a

-CA$4m

Jun 30 2023n/an/a

-CA$4m

Mar 31 2023n/an/a

-CA$4m

Dec 31 2022CA$303kCA$242k

-CA$4m

Sep 30 2022n/an/a

-CA$4m

Jun 30 2022n/an/a

-CA$5m

Mar 31 2022n/an/a

-CA$5m

Dec 31 2021CA$329kCA$225k

-CA$5m

Sep 30 2021n/an/a

-CA$4m

Jun 30 2021n/an/a

-CA$4m

Mar 31 2021n/an/a

-CA$3m

Dec 31 2020CA$353kCA$225k

-CA$4m

Sep 30 2020n/an/a

-CA$4m

Jun 30 2020n/an/a

-CA$4m

Mar 31 2020n/an/a

-CA$2m

Dec 31 2019CA$311kCA$225k

-CA$960k

Sep 30 2019n/an/a

-CA$510k

Jun 30 2019n/an/a

-CA$685k

Mar 31 2019n/an/a

-CA$3m

Dec 31 2018CA$85kCA$67k

-CA$3m

Sep 30 2018n/an/a

-CA$4m

Jun 30 2018n/an/a

-CA$4m

Mar 31 2018n/an/a

-CA$4m

Dec 31 2017CA$18kn/a

-CA$3m

Compensation vs Market: Marc's total compensation ($USD289.22K) is above average for companies of similar size in the Canadian market ($USD167.77K).

Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.

CEO

Marc Edwards

6.2yrs

Tenure

CA$406,832

Compensation

Mr. Marc Edwards is the Founder and President of VetRx, a Montreal-based technology company specializing in daollection, cleansing, marketing and pharmaceutical compliance for the veterinary industry. Mr....

Leadership Team

NamePositionTenureCompensationOwnership
Marc Edwards
President6.2yrsCA$406.83k4.64%
CA$ 734.1k
Ray Dupuis
Chief Financial Officer7.2yrsCA$231.39k0.72%
CA$ 113.3k
Robert Huizinga
Executive Chairman & Member of Scientific Advisory Board6.2yrsno data0.24%
CA$ 38.2k
Gregory Schultz
Chief Scientific Officer & Member of Scientific Advisory Board2.6yrsno datano data
Lorne Gorber
Investor Relationsno datano datano data
Wendy Nachtigall
Director of Marketingno datano datano data
Lori Christofalos
Chief Quality Officerless than a yearno datano data
Nicole Sendey
Investor Relations Adviserno datano datano data

2.6yrs

Average Tenure

Experienced Management: KNE's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Marc Edwards
President8.8yrsCA$406.83k4.64%
CA$ 734.1k
Robert Huizinga
Executive Chairman & Member of Scientific Advisory Board6.2yrsno data0.24%
CA$ 38.2k
Gregory Schultz
Chief Scientific Officer & Member of Scientific Advisory Board2.8yrsno datano data
Georges Morin
Independent Director4.5yrsCA$41.53k0.11%
CA$ 17.2k
Philip Renaud
Vice Chairman14.2yrsCA$44.73k18.46%
CA$ 2.9m
Rashieda Gluck
Member of Scientific Advisory Board6.2yrsCA$13.30kno data
Gordon Guay
Chairman of Scientific Advisory Board6.2yrsno datano data
John Coleman
Independent Directorless than a yearCA$2.25kno data

6.2yrs

Average Tenure

Experienced Board: KNE's board of directors are considered experienced (6.2 years average tenure).